<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38494719</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1349-7235</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Internal medicine (Tokyo, Japan)</Title><ISOAbbreviation>Intern Med</ISOAbbreviation></Journal><ArticleTitle>The Epidemiology of Circulating Respiratory Pathogens during the COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>1683</StartPage><EndPage>1687</EndPage><MedlinePgn>1683-1687</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.3266-23</ELocationID><Abstract><AbstractText>Objective To survey the epidemiology of respiratory pathogens during the coronavirus disease 2019 (COVID-19) pandemic using multiplex polymerase chain reaction (PCR). Methods Specimens were assayed using multiplex nested PCR. Materials Specimens were obtained from outpatients who presented with symptoms of upper respiratory tract infection and asymptomatic outpatients who had contact with patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at Tohoku Medical and Pharmaceutical University Hospital in Sendai, Japan, from November 1, 2020, to May 31, 2023. The analysis included multiple specimens collected from the same patients at different time-points. Data were collected from the electronic records after testing. Results This study included 8,335 patients (4,311 men) with a median age of 59 years old, and 11,741 total specimens were collected. At least 1 positive SARS-CoV-2 result was obtained for 1,710 (14.6%) specimens. Furthermore, 15 pathogens were identified in the positive specimens, and rhinovirus/enterovirus was detected more frequently than other viruses. We identified a larger number of SARS-CoV-2-positive specimens in patients â‰¥10 years old. In contrast, in patients 0-9 years old, we identified a larger number of specimens positive for rhinovirus/enterovirus than for other viruses. Conclusion In this study, we examined the epidemiology of circulating respiratory pathogens during the COVID-19 pandemic era.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Imai</LastName><ForeName>Haruka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Shota</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Daishi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Makiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Shiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaku</LastName><ForeName>Mitsuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Intern Med</MedlineTA><NlmUniqueID>9204241</NlmUniqueID><ISSNLinking>0918-2918</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">multiplex polymerase chain reaction assay</Keyword><Keyword MajorTopicYN="N">respiratory pathogens</Keyword></KeywordList><CoiStatement>
<b>The authors state that they have no Conflict of Interest (COI).</b>
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38494719</ArticleId><ArticleId IdType="pmc">PMC11239251</ArticleId><ArticleId IdType="doi">10.2169/internalmedicine.3266-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, et al. ;the China Novel Coronavirus Investingating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382: 727-733, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Weekly epidemiological update on COVID-19 - 11 2023 May [Internet]. 2023 May 11 [cited 2023 Mar 15]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---11-may-2023/</Citation></Reference><Reference><Citation>Bai Y, Tao X. Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ Sci B 22: 87-98, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885750</ArticleId><ArticleId IdType="pubmed">33615750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MP, Papenburg J, Desjardins M, et al. . Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review. Ann Intern Med 172: 726-734, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170415</ArticleId><ArticleId IdType="pubmed">32282894</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry GJ, Zhen W, Smith E, et al. . Multicenter evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for detection of SARS-CoV-2 in nasopharyngeal swab samples. J Clin Microbiol 60: e0006622, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9116161</ArticleId><ArticleId IdType="pubmed">35387475</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Infectious Disease. Coronavirus disease (COVID-19) [Internet]. [cited 2023 Mar 15]. Available from: https://www.niid.go.jp/niid/en/</Citation></Reference><Reference><Citation>Takashita E, Kawakami C, Momoki T, et al. . Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses 15: 488-494, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189209</ArticleId><ArticleId IdType="pubmed">33715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Diesner-Treiber SC, Voitl P, Voitl JJM, et al. . Respiratory infections in children during a Covid-19 pandemic winter. Front Pediatr 9: 740785, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558488</ArticleId><ArticleId IdType="pubmed">34733808</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Winn A, Dahl RM, Kniss KL, Silk BJ, Killerby ME. Seasonality of common human coronaviruses, United States, 2014-2021. Emerg Infect Dis 28: 1970-1976, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514339</ArticleId><ArticleId IdType="pubmed">36007923</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, et al. . Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics 148: e2021051462, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Labour and Welfare. Information regarding SARS-CoV-2 vaccination in Japan [Internet]. [cited 2023 Jul 8]. Available from: https://www.cov19-vaccine.mhlw.go.jp/qa/ (in Japanese)</Citation></Reference><Reference><Citation>CDC COVID-19 Response Team. Coronavirus disease 2019 in children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 69: 422-426, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147903</ArticleId><ArticleId IdType="pubmed">32271728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323: 2427-2429, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240631</ArticleId><ArticleId IdType="pubmed">32432657</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, HyypiÃ¤ T. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 197: 382-389, 2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">18248302</ArticleId></ArticleIdList></Reference><Reference><Citation>Creager HM, Cabrera B, Schnaubelt A, et al. . Clinical evaluation of the BioFireâ“‡ Respiratory Panel 2.1 and detection of SARS-CoV-2. J Clin Virol 129: 104538, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336953</ArticleId><ArticleId IdType="pubmed">32650276</ArticleId></ArticleIdList></Reference><Reference><Citation>Information regarding SARS-CoV-2 vaccination in Sendai City [Internet]. [cited 2023 May 12]. Available from: https://www.city.sendai.jp/covidvaccine/sessyuzyoukyou.html (in Japanese)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>